Latest News


New Treatment

Kolling NEWS .

Our Kolling Institute newsletter brings together a collection of profiles on our impressive researchers. Flip through our flipping book to discover more about our leading research into kidney disease, rare cancers and the use of supplements for osteoarthritis. There's a focus too on the first steps towards gene therapy for Meniere's disease, the latest research into treatments for dementia and.....
Read more

Category: New Treatment, Newsletters, Research Excellence

Spotlight on clinical trials .

Kolling Institute researcher and Royal North Shore Hospital endocrinologist Professor Rory Clifton-Bligh has been involved in clinical trials for more than 20 years, focusing on conditions such as osteoporosis, thyroid cancer and diabetes. Patients in the endocrinology clinic have sometimes accessed medication 10 years ahead of other Australians. Many of these drugs have gone on to be listed on the.....
Read more

Category: New Treatment, Research Excellence

Leading new centre to strengthen cancer research and expertise.

Researchers at the Kolling Institute have welcomed the launch of Australia's premier cancer clinical trials centre on the Royal North Shore Hospital campus. NORTH Sydney Trials and Research Van Norton Poche or NORTH STAR VNP has been made possible by a $20 million gift from the late Kay Van Norton Poche and her husband Greg. The centre is a ground-breaking partnership between Northern Sydney Local .....
Read more

Category: Funding support, New Treatment, Research Excellence

Innovative musculoskeletal program heads to the bush.

In a sign of the strength of the Kolling Institute’s research and clinical capabilities, Professor Trudy Rebbeck has been awarded a $2.5 million grant to offer a musculoskeletal care program in rural and remote parts of Australia. As a Professor of Allied Health and a physiotherapist, Trudy will lead the collaborative project involving University of Sydney, NSLHD and Kolling Institute researchers M.....
Read more

Category: Funding support, Musculoskeletal Research, Neuroscience and Pain Research, New Treatment

Kolling Institute researchers instrumental in Australian first guidelines .

It has taken three years and many hours of careful work, but two researchers from the John Walsh Centre for Rehabilitation Research have developed the first clinical practice guidelines for physiotherapists to inform the care of people with life-changing spinal cord injuries. Physiotherapy is a key part of rehabilitation for people with a spinal cord injury, but until now, there has been no nationa.....
Read more

Category: Neuroscience and Pain Research, New Treatment, Research Excellence

Digital technology to support those with long-standing pain.

Researchers based at the Kolling Institute have launched a clinical trial using digital health technology to help those with chronic pain reduce their use of opioids. Chief investigator and leading pain specialist at Royal North Shore Hospital Professor Paul Glare said many people with chronic pain are using opioid medications long-term, but research shows that in many cases, these medications are .....
Read more

Category: Neuroscience and Pain Research, New Treatment

Combined digital interventions improve recovery following knee replacement surgery.

For the thousands of people who undergo a total knee replacement each year, a new technological approach may hold the key to a better recovery following surgery. Researchers from the Kolling Institute conducted a randomized clinical trial, investigating whether a digital technology package delivered remotely was effective in reducing pain and improving mobility after a knee replacement. Dr Vicky Du.....
Read more

Category: Musculoskeletal Research, New Treatment, Research Excellence

Kolling researchers leading the fight against diabetes.

With a concerning rise in the number of people developing Type 2 diabetes, our researchers at the Kolling Institute are offering hope and an effective way forward to reduce the impact of the serious disease. Type 2 diabetes is the fastest growing chronic disease in the world, and if the current trend continues, it’s anticipated close to three million Australians will have the disease by 2025. It of.....
Read more

Category: Cardiovascular and Renal Research, New Treatment, Research Excellence

Technology delivering support to those with back pain anywhere, any time.

With the number of people living with low back pain escalating sharply, researchers are turning to widely-accessible technology to reduce the impact of the disabling condition. The team from the University of Sydney and the Kolling Institute has launched a study measuring the effectiveness of a mobile health program which offers self-management strategies via text messages. Study lead Professor Man.....
Read more

Category: Musculoskeletal Research, New Treatment, Research Excellence

Australian researchers uniquely positioned to support upcoming space missions.

The expertise across Australia’s space medicine community was showcased during a special event co-ordinated by the Kolling Institute and the Australasian Society of Aerospace Medicine. Staged over two days, the colloquium involved national and international experts including representatives from the Australian Space Agency, the CSIRO, Boeing and the Australian Antarctic Program. Presenters discusse.....
Read more

Category: New Treatment, Research Excellence